BioAtla (BCAB) Enterprise Value Growth (1y) (2021 - 2026)
BioAtla (BCAB) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.94% |
| Dec 31, 2025 | 85.49% |
| Sep 30, 2025 | 85.28% |
| Jun 30, 2025 | 70.47% |
| Mar 31, 2025 | 59.86% |
| Dec 31, 2024 | 56.00% |
| Sep 30, 2024 | 60.00% |
| Jun 30, 2024 | 63.45% |
| Mar 31, 2024 | 58.15% |
| Sep 30, 2023 | 20.68% |
| Jun 30, 2023 | 16.61% |
| Mar 31, 2023 | 12.19% |
| Sep 30, 2022 | 34.01% |
| Jun 30, 2022 | 2.56% |
| Mar 31, 2022 | 0.80% |
| Dec 31, 2021 | -2.67% |
| Sep 30, 2021 | -375.58% |
| Jun 30, 2021 | -112,730.98% |
| Mar 31, 2021 | -59,683.51% |